The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Biomerieux Inc., a manufacturer of in vitro diagnostic products, for bacterial identification and antibiotic susceptibility testing services. The $225,119.87 contract has a period of performance through March 2026 and does not involve any set-aside designations. Biomerieux, through its Biomerieux, Inc. division, will provide the VA's healthcare facilities with its proprietary VITEK, BioFire, and VIDAS diagnostic platforms, along with associated reagents and test kits. The company has several Indefinite Delivery Vehicles (IDVs), including a $194 million Federal Supply Schedule contract for in vitro diagnostics, which facilitate ongoing procurement of its specialized solutions by federal agencies. The contract award supports the VA's clinical laboratory operations and infectious disease testing requirements across its integrated healthcare network.
Generated 3/5/25, 9:52 AM